Effects of Tumor Necrosis Factor Alpha Blocker Adalimumab in Experimental Spinal Cord Injury

BÖRCEK A. Ö., Civi S., Ocal O., GÜLBAHAR Ö.

JOURNAL OF KOREAN NEUROSURGICAL SOCIETY, cilt.57, sa.2, ss.73-76, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 57 Sayı: 2
  • Basım Tarihi: 2015
  • Doi Numarası: 10.3340/jkns.2015.57.2.73
  • Dergi Adı: JOURNAL OF KOREAN NEUROSURGICAL SOCIETY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.73-76
  • Gazi Üniversitesi Adresli: Evet

Özet

Objective : Tumor necrosis factor alpha (TNF-alpha) have proven effects in pathogenesis of neuroinflammation after spinal cord injury (SCI). Current study is designed to evaluate the effects of an anti-TNF-alpha agent, adalimumab, on spinal cord clip compression injury in rats.